MBX Biosciences, Inc.

MBX ·Healthcare, Drug Manufacturers - General, United States
Financial Statements Balance Sheet
Annual Quarterly

Balance Sheet

Line Item Dec 2023
Assets
Cash & Equivalents $30.5M
Accounts Receivable
Inventory
Total Current Assets $83.5M
Property, Plant & Equipment $439.0K
Goodwill
Intangible Assets (Excl. Goodwill)
Total Assets $84.2M
Liabilities
Accounts Payable $1.4M
Total Current Liabilities $3.9M
Long-Term Debt
Total Liabilities $4.3M
Stockholders' Equity
Retained Earnings $-75.6M
Total Stockholders' Equity $-72.5M
← Newer Page 2 of 2 Older →